We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
147 hedge funds and large institutions have $892M invested in Rocket Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 60 increasing their positions, 40 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
160% more call options, than puts
Call options by funds: $848K | Put options by funds: $326K
50% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 40
5% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 22
1% less funds holding
Funds holding: 149 → 147 (-2)
1.39% less ownership
Funds ownership: 99.81% → 98.41% (-1.4%)
14% less capital invested
Capital invested by funds: $1.04B → $892M (-$145M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
147
Holders Change
-2
Holders Change %
-1.34%
% of All Funds
2.48%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
23
Increased
60
Reduced
40
Closed
22
Calls
$848K
Puts
$326K
Net Calls
+$522K
Net Calls Change
+$707K
Top Buyers
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
+$13.8M |
| 2 |
BlackRock
New York
|
+$8.04M |
| 3 |
GC
GMT Capital
Atlanta,
Georgia
|
+$5.92M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
+$4.76M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$4.45M |
